🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HCM

Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy NCT06730464n/a4 sites📍 Milan📍 Lispon📍 Barcelona Centro Medico Teknon Multimodal Analysis of Endomyocardial Biopsies NCT07359690n/a1 site📍 Essen University Hospital, Essen Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy NCT05569382Phase 44 sites📍 Aarhus N📍 Odense📍 Roskilde Morten Steen Kvistholm Jensen · Tests: Verapamil, Bisoprolol, Placebo MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies NCT06555237Phase 21 site📍 Warsaw Medical University of Warsaw · Tests: Trametinib tablet, Standard therapy Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial NCT07120776NA1 site📍 Manchester University of Manchester · Tests: Camzyos (Mavacamten) Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis NCT06381778n/a1 site📍 New Taipei City Far Eastern Memorial Hospital Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases NCT07464132Phase 1, Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Injection of 68Ga-NI-FAPI DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies NCT04265040n/a1 site📍 Heidelberg University Hospital Heidelberg Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443n/a3 sites📍 Bologna📍 Roma📍 Florence IRCCS Azienda Ospedaliero-Universitaria di Bologna A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy NCT07021963Phase 21 site📍 Beijing Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-1893 Tablet Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients NCT06490250NA1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: Inspiratory Muscle Training, Baduanjin Exercise The Chinese Hypertrophic Cardiomyopathy Study(CHCS) NCT02696135n/a1 site📍 Beijing China National Center for Cardiovascular Diseases Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition NCT06409585n/a1 site📍 Edinburgh University of Edinburgh · Tests: 68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR, Echocardiogram, Cardiac MRI Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy NCT03846297n/a1 site📍 Boulogne-Billancourt Assistance Publique - Hôpitaux de Paris Real-world Patient Reported Outcomes Among Patients Treated With Camzyos NCT06551129n/a1 site📍 Boston Bristol-Myers Squibb · Tests: Mavacamten ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy NCT06580717Phase 41 site📍 Seoul Yonsei University · Tests: enavogliflozin 0.3mg, enavogliflozin Placebo Molecular and Imaging Studies of Cardiovascular Health and Disease NCT02804269n/a1 site📍 Singapore National Heart Centre Singapore · Tests: Cardiovascular Magnetic Resonance, Fatmass measurement Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging NCT05081115n/a1 site📍 Benevento Fatebenefratelli Hospital · Tests: ABCDE-Stress Echo, SE diastolic assessment, SE Right ventricular function assessment, SE in heart donors Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy NCT05818605NA1 site📍 San Francisco University of California, San Francisco · Tests: Moderate Intensity Exercise Program Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center Large Language Models To Improve the Quality of Care of Cardiology Patients NCT06935253NA1 site📍 Palo Alto Stanford University · Tests: Large Language Model Austrian Hypertrophic Cardiomyopathy Registry NCT06368518n/a15 sites📍 Linz📍 Sankt Pölten📍 Wiener Neustadt Medical University of Graz The Heart Hive - Cardiomyopathy Study NCT04612296n/a1 site📍 London Imperial College London · Tests: Research genetic analysis Mavacamten Pregnancy Surveillance Program NCT05939700n/a1 site📍 Wilmington Bristol-Myers Squibb · Tests: Mavacamten Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy NCT06433050EARLY Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: Sotagliflozin BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy NCT07755904Phase 33 sites📍 Manhasset📍 Rock Hill📍 Plano Braveheart Bio, Inc. · Tests: BHB-1893, Metoprolol AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy NCT07263204n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) NCT05489705n/a101 sites📍 Anchorage📍 Tucson📍 Little Rock Bristol-Myers Squibb · Tests: Mavacamten, Non-mavacamten symptomatic oHCM therapy Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy NCT07077005NA1 site📍 Munich Technical University of Munich · Tests: Exercise training Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy NCT05610215NA1 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: hybrid ablation, catheter ablation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy